Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients
NCT02403089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-02-03
Summary
The objective of this study is 1/ to determine the rate and kinetics of MAIT cell expansion and maturation in neonates in relation with gestational age, and in HSCT recipient children in relation with the source of donor stem cells, 2/ to correlate gut microbiota diversity and function with MAIT cell maturation and function in neonates and HSCT recipients; and 3/ to link MAIT cells and gut microbiota composition with microbial infections and severe intestinal inflammatory events in term and preterm neonates, and in HSCT recipients
Conditions
- Term and Preterm Neonates (24-41 Weeks Gestational Age)
- Hematopoietic Stem Cell Transplant Recipient Children
Interventions
- OTHER
-
Tubes fund recovery blood count
Tubes fund recovery of blood counts among newborns
- OTHER
-
the rest of the blood test and stool sample
blood samples on the recovery kinetics after transplant. The rest of the blood test and stool sample done as part of a routine examination.
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
collaborator OTHER -
Institut Curie
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Biran Valérie, PHD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 1 Day
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2018-02-28
- Completion
- 2018-02-28
Countries
- France
Study Locations
More Related Trials
-
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
NCT06904053 ·Status: RECRUITING
-
Microbiome Alterations in IL10RA-deficient Patients After HSCT
NCT03752372 ·Status: TERMINATED
-
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation
NCT04804891 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
NCT04629430 ·Status: COMPLETED ·Phase: NA
-
Iron Overload in Stem Cell Transplant Recipients
NCT00806715 ·Status: COMPLETED
-
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
NCT02598752 ·Status: COMPLETED
-
Gut Decontamination In Pediatric Allogeneic Hematopoietic
NCT02641236 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
NCT02338479 ·Status: UNKNOWN
-
Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers
NCT02940093 ·Status: UNKNOWN
-
Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients
NCT04281797 ·Status: UNKNOWN
-
A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant
NCT04494061 ·Status: TERMINATED
-
Markers of Inflammation in Hematopoietic Stem Cell Transplant
NCT00579397 ·Status: COMPLETED
-
Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)
NCT02737384 ·Status: TERMINATED ·Phase: PHASE2
-
Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT
NCT06143501 ·Status: RECRUITING
-
Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation
NCT03357172 ·Status: RECRUITING ·Phase: NA
-
Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation
NCT01629017 ·Status: RECRUITING
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING
-
Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.
NCT02032381 ·Status: COMPLETED ·Phase: NA
-
The Association of Microbiota Composition With cGVHD After Allo-HSCT
NCT05355675 ·Status: UNKNOWN
-
Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease
NCT02225145 ·Status: COMPLETED
-
FMT In High-Risk Acute GVHD After ALLO HCT
NCT04139577 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-center Clinical Study of Cord Blood Stem Cell Transplantation for IBD Caused by IL-10R Gene Deficiency
NCT04170192 ·Status: UNKNOWN
-
An Exploratory Study of the Characteristics of and Challenges for International Families Seeking Medical Care in the United States
NCT01211990 ·Status: COMPLETED
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)
NCT03720392 ·Status: TERMINATED ·Phase: PHASE2